Riskpilot← Back to searchSign inGet full accessHHS GRUPPEN A/S
A/SActiveCVR 27066577Romancevej 41Wholesale of chemical products · NACE 4685Est. 20033 employees
Revenue 2024
DKK 3M
+30% vs 2023
EBITDA margin
44.5%
+61% vs 2023
Equity ratio
80.2%
Financial strength
Net profit 2024
DKK 917K
+65% vs 2023
| Revenue | DKK 3M | +30% |
| EBITDA | DKK 1,3M | +61% |
| Net profit | DKK 917K | +65% |
| Total assets | DKK 5,4M | -1% |
| Equity | DKK 4,4M | +13% |
| Employees | 3 | — |
Legal name
HHS GRUPPEN A/S
CVR number
27066577
Legal form
Aktieselskab
NACE code
4685 · Wholesale of chemical products
Founded
14. marts 2003
Share capital
DKK 500.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to bestyrelsesmedlemmer eller af en direktør.
Company purpose
Selskabets formål er import, produktion og handel med skadedyrsprodukter samt pelsopbevaring med aktiviteter i tilknytning hertil samt anden beslægtet virksomhed.
Address
Romancevej 41
Phone
+4544945055
Email
info@hhsgruppen.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2.706 | 1.982 | 2.303 | 2.296 | 2.977 |
| Staff expenses | -1.578 | -1.514 | -1.461 | -1.475 | -1.654 |
| EBITDA | 1.128 | 467 | 842 | 821 | 1.323 |
| Depreciation & amort. | -61 | -89 | -89 | -93 | -106 |
| EBIT | 1.067 | 378 | 752 | 728 | 1.218 |
| Net financials | -7 | -36 | -57 | -16 | -43 |
| Profit before tax | 1.060 | 342 | 695 | 712 | 1.175 |
| Tax | 235 | 73 | 153 | 157 | 258 |
| Net profit | 825 | 269 | 541 | 555 | 917 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5.855 | 4.948 | 5.399 | 5.477 | 5.431 |
| Equity | 3.600 | 3.370 | 3.681 | 3.836 | 4.353 |
| Long-term debt | 785 | 661 | 537 | 0 | 0 |
| Short-term debt | 1.378 | 821 | 1.064 | 1.524 | 965 |
| Total debt | 2.163 | 1.482 | 1.601 | 1.524 | 965 |
EBITDA margin
44.5%
This company
15.8%
Market median
+182% vs market
20202024
Equity ratio
80.2%
This company
38.2%
Market median
+110% vs market
20202024
Return on equity
21.1%
This company
18.4%
Market median
+15% vs market
20202024
Net profit margin
30.8%
This company
8.1%
Market median
+280% vs market
20202024
Asset turnover
0.55×
This company
1.12×
Market median
-51% vs market
20202024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HH Management | Management | 2003 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2012 | |
| Chairman | 2019 | |
| Former (1) | ||
| Board of Directors | 2012 – 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2018 | |
| Company | 50–66.65% | 50–66.65% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
H.H.V Holding ApS
HHS GRUPPEN A/S Board members of HHS GRUPPEN A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Henrik Videbæk | Management | 0 companies |
| Sten Buchhave Biilmann | Board of Directors | 0 companies |
| Henrik Ørum | Chairman | 0 companies |
| Helle Lunde Rasmussen | Board of Directors | 0 companies |